izpis_h1_title_alt

Gene immunotherapy of colon carcinoma with IL-2 and IL-12 using gene electrotransfer
ID Komel, Tilen (Author), ID Omerzel, Maša (Author), ID Kamenšek, Urška (Author), ID Žnidar, Katarina (Author), ID Lampreht Tratar, Urša (Author), ID Kranjc Brezar, Simona (Author), ID Dolinar, Klemen (Author), ID Pirkmajer, Sergej (Author), ID Serša, Gregor (Author), ID Čemažar, Maja (Author)

.pdfPDF - Presentation file, Download (6,91 MB)
MD5: DA9CE0EFC9195E902CCA271685FE608E
URLURL - Source URL, Visit https://www.mdpi.com/1422-0067/24/16/12900 This link opens in a new window

Abstract
Gene immunotherapy has become an important approach in the treatment of cancer. One example is the introduction of genes encoding immunostimulatory cytokines, such as interleukin 2 and interleukin 12, which stimulate immune cells in tumours. The aim of our study was to determine the effects of gene electrotransfer of plasmids encoding interleukin 2 and interleukin 12 individually and in combination in the CT26 murine colon carcinoma cell line in mice. In the in vitro experiment, the pulse protocol that resulted in the highest expression of IL-2 and IL-12 mRNA and proteins was used for the in vivo part. In vivo, tumour growth delay and also complete response were observed in the group treated with the plasmid combination. Compared to the control group, the highest levels of various immunostimulatory cytokines and increased immune infiltration were observed in the combination group. Long-term anti-tumour immunity was observed in the combination group after tumour re-challenge. In conclusion, our combination therapy efficiently eradicated CT26 colon carcinoma in mice and also generated strong anti-tumour immune memory.

Language:English
Keywords:colon carcinoma, gene electrotransfer, gene immunotherapy, CT26 colon carcinoma, IL-2, IL-12, anti-tumour immune memory
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:MF - Faculty of Medicine
ZF - Faculty of Health Sciences
Publication status:Published
Publication version:Version of Record
Year:2023
Number of pages:25 str.
Numbering:Vol. 24, iss. 16, art. 12900
PID:20.500.12556/RUL-164842 This link opens in a new window
UDC:602.6/.7
ISSN on article:1422-0067
DOI:10.3390/ijms241612900 This link opens in a new window
COBISS.SI-ID:162334211 This link opens in a new window
Publication date in RUL:13.11.2024
Views:78
Downloads:12
Metadata:XML DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:International journal of molecular sciences
Shortened title:Int. j. mol. sci.
Publisher:MDPI
ISSN:1422-0067
COBISS.SI-ID:2779162 This link opens in a new window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Secondary language

Language:Slovenian
Keywords:rak debelega črevesa, elektroprenos genov, genska imunoterapija

Projects

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P3-0003
Name:Razvoj in ovrednotenje novih terapij za zdravljenje malignih tumorjev

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:J3-2528
Name:Imunski genski elektroprenos IL-12 in IL-2 za zdravljenje imunološko hladnih/vročih tumorjev

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P3-0043
Name:Molekularni mehanizmi razvoja in delovanja skeletne mišice

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:J7-3153
Name:Molekularni mehanizmi specifičnosti pri uravnavanju izločanja in delovanja citokinov mišičnega izvora

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back